AZETIDINE COMPOUNDS AS GRP119 MODULATORS FOR THE TREATMENT OF DIABETES, OBESITY, DYSLIPIDEMIA AND RELATED DISORDERS

• 收藏
• 分享

专利权人:

发明人:

Lothar Schwink,Christian Buning,Heiner Glombik,Christoph Poverlein,Kurt Ritter,Nis Halland,Matthias Lohmann

申请号：

US15899842

公开号：

US20180237419A1

申请日:

2018.02.20

申请国别(地区):

US

年份:

2018

代理人:

摘要：

The present disclosure relates to azetidine compounds. The azetidine compounds are GPR119 modulators and useful for the prevention and/or treatment of diabetes, obesity, dyslipidemia and related disorders. The present disclosure furthermore relates to the use of azetidine compounds as active ingredients in pharmaceuticals, and pharmaceutical compositions comprising them.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/